Details for Patent: 8,980,873
✉ Email this page to a colleague
Which drugs does patent 8,980,873 protect, and when does it expire?
Patent 8,980,873 protects VONJO and is included in one NDA.
This patent has twenty-eight patent family members in twenty-three countries.
Summary for Patent: 8,980,873
| Title: | 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.- 1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt |
| Abstract: | The present invention relates to certain salts of a 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1- .1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (Compound I) which have been found to have improved properties. In particular the present invention relates to the citrate salt of this compound. The invention also relates to pharmaceutical compositions containing the citrate salt and methods of use of the citrate salt in the treatment of certain medical conditions. ##STR00001## |
| Inventor(s): | Dymock; Brian (Singapore, SG), Lee; Cheng H. (Singapore, SG), William; Anthony D. (Singapore, SG) |
| Assignee: | CTI Biopharma Corp. (Seattle, WA) |
| Application Number: | 13/133,297 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Compound; |
Drugs Protected by US Patent 8,980,873
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cti Biopharma Corp | VONJO | pacritinib citrate | CAPSULE;ORAL | 208712-001 | Feb 28, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | TREATMENT OF MYELOFIBROSIS WITH PACRITINIB | ⤷ Sign Up | ||
| Cti Biopharma Corp | VONJO | pacritinib citrate | CAPSULE;ORAL | 208712-001 | Feb 28, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | USE OF PACRITINIB FOR INHIBITING JANUS ASSOCIATED KINASE 2(JAK2) | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,980,873
| PCT Information | |||
| PCT Filed | December 09, 2009 | PCT Application Number: | PCT/SG2009/000473 |
| PCT Publication Date: | June 17, 2010 | PCT Publication Number: | WO2010/068181 |
International Family Members for US Patent 8,980,873
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 074724 | ⤷ Sign Up | |||
| Argentina | 114133 | ⤷ Sign Up | |||
| Australia | 2009325147 | ⤷ Sign Up | |||
| Brazil | PI0922736 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
